Detecting cancer early can make a world of difference. Freenome is setting a new pace for early cancer detection by combining the latest in science and artificial intelligence, with the ease of a standard blood draw.
Outpacing cancer starts with early detection
Detecting cancer early can make a world of difference. Freenome is setting a new pace for early cancer detection by combining the latest in science and artificial intelligence, with the ease of a standard blood draw.
A novel approach to screening
Freenome’s intelligent screening platform uses multiomics technology to detect cancer in its earliest, most treatable stages.